CLINICAL_TRIALS
trial_result
· 2017-01-12
Clinical Trial Update: Buprenorphine for the Treatment of Neonatal Abstinence Syndrome [Phase 1]
Summary
The document reports the completion of a Phase 1 study evaluating buprenorphine for the treatment of Neonatal Abstinence Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thomas Jefferson University | Conditions: Neonatal Abstinence Syndrome | Phase 1 | Status: COMPLETED